There couldn’t be a more pressing or galvanizing topic for Americans than the high cost of prescription drugs. And after ...

Academic scientists and pharmaceutical companies alike are embracing artificial intelligence, even as questions linger about ...

The pharmaceutical industry faces policy volatility with new tariffs, MFN pricing, and marketing rule changes, impacting ...

WiMi Hologram Cloud Inc. (NASDAQ: WiMi) ('WiMi' or the 'Company'), a leading global Hologram Augmented Reality ('AR') Technology provider, today announced that active exploration is underway in the ...

Global mortality rates are falling but not among youths and young adults, according to the latest Global Burden of Disease ...

From October 12-18, celebrate your vet techs (and the tasks they do behind the scenes!) during National Veterinary Technician ...

Pharmaceutical stocks are having a moment. The S&P 500 Pharmaceuticals Index recently rose 11% during five trading days, its ...

Denali Therapeutics Inc. (Nasdaq: DNLI) today announced that the U.S. Food and Drug Administration (FDA) has extended its review timeline of the Biologics License Application (BLA) seeking accelerated ...

The authors describe an interesting approach to studying the dynamics and function of membrane proteins in different lipid environments. The important findings have theoretical and practical ...

A new report out from the credit rating company Moody's says 22 states, including Maine, are either in a recession or will be in one soon. Some Mainers say they are not surprised to hear this.

The enhanced premium tax credits are set to expire at the end of 2025 and are at the center of the government shutdown.

What is the best way to build working-class power when labor’s leverage over capital is near a historic low? With ...